Market Cap

Passage Bio, Inc. Market Capitalization:

$28.7 Million

USD as of July 1, 2025

business Passage Bio, Inc. Company Profile

Passage Bio, Inc. Main Stock Listing

NASDAQ: PASG

Market Capitalization History of Passage Bio, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Passage Bio, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $46.9 M -7.75%
Jan. 1, 2024 $50.8 M -44.22%
Jan. 1, 2023 $91.1 M -69.18%
Jan. 1, 2022 $295.6 M -73.04%
Jan. 1, 2021 $1.10 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Passage Bio, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Passage Bio, Inc. has the following listings and related stock indices.


Stock: NASDAQ: PASG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.